VOLITIONRX LTD

AUSTIN, TX How do I update this listing?

Volitionrx LTD is based out of Austin. VolitionRX is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. VolitionRX is managed by a well-respected team with extensive experience in diagnostics and commercialization.Whalewisdom has at least 88 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-08-27. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Other

Create Email Alert

Contact Info

volitionrx ltd
13215 BEE CAVE PARKWAY
AUSTIN TX    78738

Business Phone: 1 (646) 650-1351
SEC SIC CODE:
2835-IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-08-27 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Other 24,000,000 24,000,000 0
2014-11-21 D BIOTECHNOLOGY Equity 721,849 721,849 0
2014-10-14 D BIOTECHNOLOGY Equity 229,393 229,393 0
2014-10-14 D BIOTECHNOLOGY Equity 750,000 750,000 0
2014-09-25 D BIOTECHNOLOGY Equity 1,189,749 1,189,749 0
2014-03-11 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 3,000,000 3,000,000 0
2013-12-03 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 1,000,000 934,923 65,077
2013-06-14 D BIOTECHNOLOGY Equity 1,500,000 595,000 905,000
2013-05-08 D BIOTECHNOLOGY Equity 500,000 416,000 84,000
2013-03-27 D BIOTECHNOLOGY Equity 500,000 489,583 10,417
2012-07-26 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 3,000,000 1,204,152 1,795,848
2011-10-28 D BIOTECHNOLOGY Equity 1,727,163 1,727,163 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALAN COLMAN subscription required
    DIRECTOR
CAMERON REYNOLDS subscription required
    EXECUTIVE OFFICER DIRECTOR
DAVID CECIL VANSTON subscription required
    EXECUTIVE OFFICER
EDWARD FUTCHER subscription required
    DIRECTOR
GUY ARCHIBALD INNES subscription required
    DIRECTOR
HABIB SKAFF subscription required
    DIRECTOR
JACOB MICALLEF subscription required
    EXECUTIVE OFFICER
JASON TERRELL subscription required
    EXECUTIVE OFFICER
KEVIN JOHN ALEXANDER subscription required
    DIRECTOR
MALCOLM LEWIN subscription required
    EXECUTIVE OFFICER
MARTIN FAULKES subscription required
    DIRECTOR
MIKE O'CONNELL subscription required
    EXECUTIVE OFFICER
RODNEY GERARD ROOTSAERT subscription required
    EXECUTIVE OFFICER
SATU VAINIKKA subscription required
    DIRECTOR

Elevate your investments